CrossRef Noninvasive Testing for Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis Markos Kalligeros, Laurent Castera, Emmanuel A
These numbers are unprecedented in the history of obesity pharmacotherapy
Through December 31, 2026, Lilly is offering eligible self-pay patients a 1-month supply of Zepbound 7.5 mg, 10 mg, 12.5 mg, and 15 mg dose KwikPens (or vials) for $449 each
Health Is More Than a Number on the Scale If your healthcare provider is recommending a GLP-1 based on lab results, its appropriate to take that seriously
In a few cases, individual studies constituted the only report on a particular treatment
Working with a healthcare provider and choosing a trusted source ensures safe, effective treatment for long-term weight management